Drug Shortage Report for DDAVP RHINYLE
| Report ID | 123857 |
| Drug Identification Number | 00402516 |
| Brand name | DDAVP RHINYLE |
| Common or Proper name | Desmopressin acetate nasal solution |
| Company Name | FERRING INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DESMOPRESSIN ACETATE |
| Strength(s) | 0.1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | NASAL NASAL |
| Packaging size | 2.5 mL |
| ATC code | H01BA |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-01-15 |
| Actual start date | 2021-01-15 |
| Estimated end date | 2021-01-27 |
| Actual end date | 2021-01-28 |
| Shortage status | Resolved |
| Updated date | 2021-03-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
| Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-09-08 | English | Compare |
| v2 | 2020-09-08 | French | Compare |
| v3 | 2020-11-02 | English | Compare |
| v4 | 2020-11-12 | English | Compare |
| v5 | 2020-11-12 | French | Compare |
| v6 | 2021-01-16 | English | Compare |
| v7 | 2021-03-02 | English | Compare |
| v8 | 2021-03-02 | French | Compare |
Showing 1 to 8 of 8